Filing Flows › Conmed (CNMD) › Gross margin
Conmed (CNMD) gross margin by quarter
Conmed's gross margin was 56.4% in Q3 2026 (third quarter 2026), -1.1 pts from Q2 2026. Over the last 7 quarters it ranged from 49.2% (Q3 2025) to 58.5% (Q4 2025).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 56.4% | -1.1 pts | +7.2 pts |
| Q2 2026 | 57.5% | -0.4 pts | +2.5 pts |
| Q1 2026 | 57.9% | -0.6 pts | +2.5 pts |
| Q4 2025 | 58.5% | +9.3 pts | — |
| Q3 2025 | 49.2% | -5.9 pts | — |
| Q2 2025 | 55.0% | -0.3 pts | — |
| Q1 2025 | 55.3% | — | — |
Q3 2026 at a glance
Conmed, Q3 2026: revenue $336M (-0.7% year over year), operating margin 11.1%, net earnings $19.8M, operating cash flow $49.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Conmed's gross margin?
Conmed's gross margin was 56.4% in Q3 2026 (third quarter 2026), -1.1 pts from Q2 2026.
How has Conmed's gross margin changed?
Over the last 7 quarters it ranged from 49.2% (Q3 2025) to 58.5% (Q4 2025).